Clinical trial · Observational
Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion
NCT05461027CI-TRIAL-00084070CP-RenalcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Percutaneous cryoablation is an alternative to urological surgery for T1a tumours, whose oncological efficacy decreases for the most central tumours due to a cold sink effect.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Kidney Cancer | Malignant Kidney Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Description of the technique of percutaneous cryoablation of central renal tumours with temporary balloon obliteration of the renal artery
- timeFrame
- Files analysed retrospectively from January 01, 2018 to December 31, 2021 will be examined
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * Adult subject (≥18 years) * Subject who has undergone cryoablation of a central kidney tumour with temporary occlusion of the renal artery by an endovascular balloon at the HUS during the period 01/01/2018 to 30/12/2021 * Subject who has not expressed his/her opposition, after information, to the re-use of his/her data for the purpose of this research. Exclusion criteria : * Subject having expressed his/her opposition to participate in the study * Subject under legal protection, guardianship or curatorship
References
Publications (0)
Data not yet available
No reference posted for this study.